Meanwhile, it is important to recognize that disruptions in VEGF-A/VEGFR2 signaling in diabetes exhibit tissue-specific patterns, and VEGF-A resistance is not uniformly present across all vascular beds. This evidence concerns the gene KDR and diabetes mellitus.